Xianlan Zhao
Overview
Explore the profile of Xianlan Zhao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Liu B, Huang D, Ma N, Xia J, Zhao X, et al.
Chin Med J (Engl)
. 2024 Oct;
PMID: 39445538
Background: T-cell lymphoblastic lymphoma/leukemia (T-LBL/ALL) is an aggressive form of hematological malignancy associated with poor prognosis in adult patients. Histone deacetylases (HDACs) are aberrantly expressed in T-LBL/ALL and are considered...
2.
Liu B, Zhao X, Zhang S, Li Q, Li X, Huang D, et al.
Leukemia
. 2024 Jan;
38(2):351-364.
PMID: 38195819
S-palmitoylation is essential for cancer development via regulating protein stability, function and subcellular location, yet the roles S-palmitoylation plays in diffuse large B-cell lymphoma (DLBCL) progression remain enigmatic. In this...
3.
Jia J, Ma B, Zhao X
Placenta
. 2023 Dec;
145:80-88.
PMID: 38100962
Endothelial colony-forming cells (ECFCs), a subset of circulating and resident endothelial progenitor cells, are capable of self-renewal and de novo vessel formation, and are known key regulators of vascular integrity...
4.
Zhao H, Zhao X
Am J Obstet Gynecol MFM
. 2023 Dec;
6(6):101253.
PMID: 38065284
No abstract available.
5.
Liu Y, Wang X, Fu W, Cao Y, Dou W, Duan D, et al.
Sci Rep
. 2023 Nov;
13(1):20392.
PMID: 37989839
No abstract available.
6.
Zhao H, Liu C, Fu H, Abeykoon S, Zhao X
Am J Obstet Gynecol MFM
. 2023 Oct;
5(12):101189.
PMID: 37832645
Background: Placenta accreta spectrum can lead to uncontrollable massive hemorrhage in the perinatal period. Currently, the first-line treatment for placenta accreta spectrum recommended worldwide is hysterectomy. However, adverse outcomes after...
7.
Liu Y, Wang X, Fu W, Cao Y, Dou W, Duan D, et al.
Sci Rep
. 2023 Sep;
13(1):16103.
PMID: 37752229
Previous studies on the relationship between dietary minerals and preeclampsia (PE) have given inconsistent results. The aim of this study was to further clarify the relationship between dietary minerals intake...
8.
Huang D, Ma N, Li X, Gou Y, Duan Y, Liu B, et al.
J Hematol Oncol
. 2023 Aug;
16(1):98.
PMID: 37612741
Cancers are a group of heterogeneous diseases characterized by the acquisition of functional capabilities during the transition from a normal to a neoplastic state. Powerful experimental and computational tools can...
9.
Liu Y, Xue R, Duan X, Shang X, Wang M, Wang F, et al.
Life Sci
. 2023 May;
326:121790.
PMID: 37211345
Aims: PARP inhibitors (PARPi) are known to exert anti-tumor effects in patients with BRCA-mutated (BRCAmut) or homologous recombination (HR)-deficient cancer, but recent clinical investigations have suggested that this treatment may...
10.
Zhou Y, Zhang X, Liu Z, Wang N, Zhao X, Guo R
Placenta
. 2023 May;
138:33-43.
PMID: 37167781
Introduction: Proliferation, migration and invasion of extravillous trophoblasts (EVTs) play an important role in the progression of preeclampsia (PE). The purpose of this study was to investigate the molecular mechanism...